Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Annals of Translational Medicine|November 9, 2017
Dendritic cell therapy in melanomaCarmen Alvarez-Dominguez, Ricardo Calderón-Gonzalez, Hector Terán-Navarro, et al.
Frontiers in Immunology|May 6, 2021
A Comparison Between Recombinant <i>Listeria</i> GAPDH Proteins and GAPDH Encoding mRNA Conjugated to Lipids as Cross-Reactive Vaccines for <i>Listeria, Mycobacterium</i>, and <i>Streptococcus</i>Hector Teran-Navarro, David Salcines-Cuevas, Ricardo Calderon-Gonzalez, et al.
Vaccines|April 3, 2021
Glyceraldehyde-3-phosphate Dehydrogenase Common Peptides of <i>Listeria monocytogenes</i>, <i>Mycobacterium marinum</i> and <i>Streptococcus pneumoniae</i> as Universal VaccinesDavid Salcines-Cuevas, Hector Terán-Navarro, Ricardo Calderón-Gonzalez, et al.
Scientific Reports|December 8, 2023
Testing a vaccine candidate against Hepatitis C virus designed by combinatorial optimizationIker Malaina, Luis Martinez, David Salcines-Cuevas, et al.
Scientific Reports|April 20, 2022
First computational design using lambda-superstrings and in vivo validation of SARS-CoV-2 vaccineLuis Martínez, Iker Malaina, David Salcines-Cuevas, et al.
Frontiers in Cellular and Infection Microbiology|November 16, 2020
Epitopes for Multivalent Vaccines Against <i>Listeria, Mycobacterium</i> and <i>Streptococcus</i> spp: A Novel Role for Glyceraldehyde-3-Phosphate DehydrogenaseCarmen Alvarez-Dominguez, David Salcines-Cuevas, Héctor Teran-Navarro, et al.
Oncoimmunology|February 5, 2019
Pre-clinical development of <i>Listeria</i>-based nanovaccines as immunotherapies for solid tumours: insights from melanomaHector Terán-Navarro, Ricardo Calderon-Gonzalez, David Salcines-Cuevas, et al.
Oncotarget|September 15, 2017
GNP-GAPDH<sub>1-22</sub> nanovaccines prevent neonatal listeriosis by blocking microglial apoptosis and bacterial disseminationRicardo Calderon-Gonzalez, Elisabet Frande-Cabanes, Hector Teran-Navarro, et al.
Pageof 1